MYH2, also known as myosin heavy chain 2, is a critical component of the contractile apparatus in skeletal muscle fibers, where it plays a central role in muscle contraction and force generation. As a member of the myosin family of motor proteins, MYH2 is responsible for converting chemical energy from ATP hydrolysis into mechanical work, enabling the sliding of actin and myosin filaments during muscle contraction. MYH2 is primarily expressed in fast-twitch skeletal muscle fibers, which are specialized for rapid and powerful contractions. Functionally, MYH2 contributes to muscle performance and exercise capacity, playing a key role in activities such as sprinting, jumping, and other high-intensity movements. Additionally, MYH2 expression is regulated by various factors, including neural activity, hormonal signals, and mechanical loading, reflecting its dynamic role in adapting skeletal muscle function to changing physiological demands.
Activation of MYH2 involves complex regulatory mechanisms that modulate its expression, post-translational modifications, and interactions with other proteins within the muscle sarcomere. One major mechanism of MYH2 activation is through transcriptional regulation, wherein signaling pathways such as the calcineurin-NFAT (nuclear factor of activated T cells) pathway and the PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) pathway stimulate MYH2 gene expression in response to various physiological stimuli, including exercise, electrical activity, and hormonal signaling. Additionally, MYH2 activity can be regulated post-transcriptionally through modifications such as phosphorylation, acetylation, and methylation, which influence its enzymatic activity, stability, and interactions with other sarcomeric proteins. Furthermore, MYH2 activation is intricately linked to calcium signaling, as calcium ions regulate the interaction between myosin and actin filaments, thereby modulating muscle contraction. Overall, the activation of MYH2 is a finely orchestrated process that integrates multiple signaling pathways and post-translational modifications to ensure proper muscle function and adaptability in response to physiological stimuli.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Stimulates PI3K-Akt signaling, promoting MYH2 expression and activity. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Activates glucocorticoid receptors, increasing MYH2 transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, which can activate MYH2 through PKA signaling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Activates retinoic acid receptors, enhancing MYH2 expression. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, leading to increased MYH2 expression and muscle fiber remodeling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that paradoxically can increase MYH2 expression under certain conditions. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates SIRT1, which can promote MYH2 expression via deacetylation of certain transcription factors. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR but can also induce stress responses that upregulate MYH2. | ||||||